Total Payments
$2,886
2024 Payments
$424.89
Companies
34
Transactions
148
Medicare Patients
1,910
Medicare Billing
$192,225
Payment Breakdown by Category
Food & Beverage$2,796 (96.9%)
Education$89.91 (3.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,796 | 143 | 96.9% |
| Education | $89.91 | 5 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $416.23 | 21 | $0 (2024) |
| PFIZER INC. | $266.17 | 14 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $225.97 | 15 | $0 (2019) |
| Amgen Inc. | $208.96 | 13 | $0 (2018) |
| GlaxoSmithKline, LLC. | $202.68 | 10 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $191.31 | 12 | $0 (2019) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $124.99 | 1 | $0 (2019) |
| Biohaven Pharmaceuticals, Inc. | $120.20 | 1 | $0 (2021) |
| Lilly USA, LLC | $118.92 | 6 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $113.03 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $424.89 | 23 | ABBVIE INC. ($332.20) |
| 2023 | $183.41 | 8 | AbbVie Inc. ($59.52) |
| 2022 | $93.58 | 4 | GlaxoSmithKline, LLC. ($52.64) |
| 2021 | $215.95 | 6 | Biohaven Pharmaceuticals, Inc. ($120.20) |
| 2020 | $112.73 | 6 | PFIZER INC. ($38.93) |
| 2019 | $628.22 | 27 | Bausch & Lomb, a division of Bausch Health US, LLC ($124.99) |
| 2018 | $519.91 | 30 | Takeda Pharmaceuticals U.S.A., Inc. ($161.95) |
| 2017 | $706.81 | 44 | Amgen Inc. ($189.38) |
All Payment Transactions
148 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.85 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.09 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.70 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Oncology | ||||||
| 08/15/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Biological | ||||||
| 08/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: NEUROSCIENCE | ||||||
| 05/09/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: VACCINES | ||||||
| 04/25/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.07 | General |
| Category: NEUROSCIENCE | ||||||
| 04/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: NEUROSCIENCE | ||||||
| 04/15/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 04/09/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $25.83 | General |
| Category: NEUROSCIENCE | ||||||
| 03/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: NEUROSCIENCE | ||||||
| 02/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $29.34 | General |
| Category: NEUROSCIENCE | ||||||
| 02/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: NEUROSCIENCE | ||||||
| 02/06/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: NEUROSCIENCE | ||||||
| 01/23/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.32 | General |
| Category: NEUROSCIENCE | ||||||
| 01/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $27.70 | General |
| Category: NEUROSCIENCE | ||||||
| 11/09/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $33.53 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2023 | PFIZER INC. | COMIRNATY (Biological), ABRYSVO | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 322 | 443 | $92,039 | $33,693 |
| 2022 | 11 | 526 | 742 | $113,658 | $53,899 |
| 2021 | 9 | 584 | 824 | $114,382 | $58,144 |
| 2020 | 12 | 478 | 709 | $140,970 | $46,489 |
Total Patients
1,910
Total Services
2,718
Medicare Billing
$192,225
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 70 | 160 | $35,520 | $10,745 | 30.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 55 | 55 | $17,655 | $8,575 | 48.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 56 | 85 | $26,605 | $8,097 | 30.4% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 12 | 12 | $3,057 | $1,542 | 50.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 20 | 20 | $2,620 | $1,439 | 54.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 45 | 45 | $2,115 | $1,020 | 48.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 25 | 25 | $1,025 | $924.00 | 90.1% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 12 | 12 | $852.00 | $591.24 | 69.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 15 | $2,100 | $576.82 | 27.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 14 | $490.00 | $184.21 | 37.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 103 | 271 | $45,335 | $18,082 | 39.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 83 | 83 | $21,460 | $12,631 | 58.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 61 | 105 | $23,154 | $9,878 | 42.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 16 | 16 | $8,406 | $4,401 | 52.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 44 | 44 | $5,764 | $3,016 | 52.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 82 | 82 | $2,871 | $1,872 | 65.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 49 | 49 | $2,009 | $1,824 | 90.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 22 | 25 | $2,500 | $963.94 | 38.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 22 | 22 | $1,202 | $826.28 | 68.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 22 | 23 | $626.90 | $309.10 | 49.3% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2022 | 22 | 22 | $330.00 | $95.13 | 28.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 133 | 313 | $46,230 | $22,416 | 48.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 93 | 93 | $21,372 | $13,969 | 65.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 82 | 122 | $29,550 | $11,595 | 39.2% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 80 | 80 | $5,600 | $5,221 | 93.2% |
About Dr. Kathryn Shade, M.D
Dr. Kathryn Shade, M.D is a Family Medicine healthcare provider based in Los Gatos, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2007. The National Provider Identifier (NPI) number assigned to this provider is 1568508877.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kathryn Shade, M.D has received a total of $2,886 in payments from pharmaceutical and medical device companies, with $424.89 received in 2024. These payments were reported across 148 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($2,796).
As a Medicare-enrolled provider, Shade has provided services to 1,910 Medicare beneficiaries, totaling 2,718 services with total Medicare billing of $192,225. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Los Gatos, CA
- Active Since 01/30/2007
- Last Updated 12/07/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1568508877
Products in Payments
- QULIPTA (Drug) $305.52
- Trintellix (Drug) $237.68
- Repatha (Biological) $144.58
- UBRELVY (Drug) $132.65
- SHINGRIX (Biological) $128.99
- ENVISTA TORIC (Device) $124.99
- NURTEC ODT (Drug) $120.20
- AJOVY (Drug) $88.32
- Livalo (Drug) $81.53
- INTRAROSA (Drug) $75.31
- INVOKANA (Drug) $71.39
- JANUVIA (Drug) $70.98
- Prolia (Biological) $64.38
- EUCRISA (Drug) $62.91
- EMGALITY (Drug) $55.20
- IMVEXXY (Drug) $52.69
- Amitiza (Drug) $47.47
- TRULICITY (Drug) $46.94
- ASMANEX (Drug) $46.15
- PREMARIN (Drug) $41.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Los Gatos
Jennifer Haggerty, M.d, M.D
Family Medicine — Payments: $6,952
Family Medicine $6,952
Rodney Gin, M.d, M.D
Family Medicine — Payments: $6,901
Family Medicine $6,901
Dr. J Zimmer, Md, MD
Family Medicine — Payments: $5,030
Family Medicine $5,030
Dr. Mary Defigard, Md, MD
Family Medicine — Payments: $4,173
Family Medicine $4,173
Dr. Norman Chow, D.o, D.O
Family Medicine — Payments: $2,790
Family Medicine $2,790
Dr. Tiffany Davies, M.d, M.D
Family Medicine — Payments: $2,734
Family Medicine $2,734